Cargando…

Heparin resistance in COVID-19 patients in the intensive care unit

Patients with COVID-19 have a coagulopathy and high thrombotic risk. In a cohort of 69 intensive care unit (ICU) patients we investigated for evidence of heparin resistance in those that have received therapeutic anticoagulation. 15 of the patients have received therapeutic anticoagulation with eith...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, D., MacDonald, S., Bull, T., Hayman, M., de Monteverde-Robb, R., Sapsford, D., Lavinio, A., Varley, J., Johnston, A., Besser, M., Thomas, W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242778/ https://www.ncbi.nlm.nih.gov/pubmed/32445064 http://dx.doi.org/10.1007/s11239-020-02145-0

Ejemplares similares

Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit
por: White, D., et al.
Publicado: (2020)

Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
por: Thomas, W., et al.
Publicado: (2020)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

High incidence of positive heparin antibodies in a multidisciplinary intensive care unit
por: Renieris, P, et al.
Publicado: (2007)

Is liquid heparin comparable to dry balanced heparin for blood gas sampling in intensive care unit?
por: Chhapola, Viswas, et al.
Publicado: (2014)

Heparin-induced thrombocytopenia during renal replacement therapy in the intensive care unit
por: Davenport, Andrew
Publicado: (2008)

Multidrug-Resistant Salmonella Typhimurium, Pacific Northwest, United States
por: Davis, Margaret A., et al.
Publicado: (2007)

Usefulness of anti-PF4/heparin antibody test for intensive care unit patients with thrombocytopenia
por: Park, Sang Hyuk, et al.
Publicado: (2012)

Orgaran(® )use in intensive care unit patients with heparin-induced thrombocytopenia and acute renal failure
por: Magnani, H, et al.
Publicado: (2007)

Direct oral anticoagulants‐Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors
por: White, Danielle, et al.
Publicado: (2022)

Use of liquid heparin for blood gas sampling in pediatric intensive care unit: A comparative study of effects of varying volumes of heparin on blood gas parameters
por: Chhapola, Viswas, et al.
Publicado: (2013)

Heparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease
por: Hayman, Erik G., et al.
Publicado: (2017)

Acquired hypofibrinogenemia: current perspectives
por: Besser, Martin W, et al.
Publicado: (2016)

Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock
por: Linder, Adam, et al.
Publicado: (2012)

The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units
por: Gurieva, Tanya, et al.
Publicado: (2018)

Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units
por: Doyle, Andrew J., et al.
Publicado: (2020)

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
por: Sholzberg, Michelle, et al.
Publicado: (2021)

A Peer and Volunteer Program for Patients and Their Families in the Pediatric Intensive Care Unit: A Pilot Program Evaluation
por: Pereira, Nichole, et al.
Publicado: (2021)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Heparin-resistance in AL amyloidosis: a case report
por: van Ede, Elisabeth S., et al.
Publicado: (2023)

Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units
por: Lavinio, Andrea, et al.
Publicado: (2021)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

To be or not to be a case of heparin resistance
por: Durrani, Jibran, et al.
Publicado: (2018)

Dynamic changes in heparin-binding protein as a prognostic biomarker for 30-day mortality in sepsis patients in the intensive care unit
por: Dou, Qing-Li, et al.
Publicado: (2022)

Managing malaria in the intensive care unit
por: Marks, M., et al.
Publicado: (2014)

Survey of tracheostomy in the intensive care unit
por: Vianna, A, et al.
Publicado: (2007)

Acute myocardial infarction: incidence and outcomes in an intensive care unit
por: Qushmaq, I, et al.
Publicado: (2005)

An intense ion source for H- cyclotrons
por: Baartman, R A, et al.
Publicado: (1986)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
por: Williams, Jonathan S., et al.
Publicado: (2018)

Single-Family Room Design in the Neonatal Intensive Care Unit—Challenges and Opportunities
por: White, Robert D.
Publicado: (2010)

Determination of fever in intensive care unit
por: Kizilkaya, M, et al.
Publicado: (2002)

An unusual cause of heparin resistance - A case report
por: Raja, Javid, et al.
Publicado: (2021)

Heparin: Drug resistance: case report
Publicado: (2020)

Clustering of Antimicrobial Resistance Outbreaks Across Bacterial Species in the Intensive Care Unit
por: Vlek, Anne L. M., et al.
Publicado: (2013)

Spatiotemporal dynamics of multidrug resistant bacteria on intensive care unit surfaces
por: D’Souza, Alaric W., et al.
Publicado: (2019)

To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
por: Bikdeli, Behnood
Publicado: (2022)

Heparin Anticoagulation Responsiveness in a Coronary Care Unit: A Prospective Observational Study
por: Alsayegh, Faisal, et al.
Publicado: (2009)

How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation
por: Barocas, Antoine, et al.
Publicado: (2023)

Tracheobronchitis in the Intensive Care Unit
por: Morrow, L., et al.
Publicado: (2010)

The effect of heparin concentration on results of venous blood gas of patients admitted to cardiac intensive care unit: A double-blind clinical trial
por: lakziyan, Rasool, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cqj3114bcuibjp6j312im6svd4